NCT01440582
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Myeloma
Explore clinical trials studying Myeloma. Study availability and eligibility vary by location and protocol.
114 public trials
22 recruiting studies
Myeloma trial results
NCT00943319
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- The University of Chicago Chicago, Illinois, United States
NCT01039025
- Conditions
- Myeloma, Neoplasms, Neoplasms by Histologic Type, +1 more
- Locations
-
- U.T. M.D. Anderson Cancer Center Houston, Texas, United States
NCT03135925
- Conditions
- Myeloma, Neoplasms, Neoplasms by Histologic Type, +1 more
- Locations
-
- Sheffield Teaching Hospitals NHS Foundation Trust Sheffield, South Yorkshire, United Kingdom
NCT01861340
- Conditions
- Myeloma, Neoplasms, Neoplasms by Histologic Type, +1 more
- Locations
-
- The Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
NCT01042704
- Conditions
- Myeloma, Neoplasms, Neoplasms by Histologic Type, +1 more
- Locations
-
- Karmanos Cancer Institute Detroit, Michigan, United States
- UPMC Cancer Centers - Teramana Cancer Center Steubenville, Ohio, United States
- UPMC Cancer Centers - Beaver Beaver, Pennsylvania, United States
- UPMC Cancer Centers - Jefferson Clairton, Pennsylvania, United States
NCT01432600
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- University of California San Francisco San Francisco, California, United States
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
- Mount Sinai School of Medicine, The Tisch Cancer Institute New York, United States
NCT00005988
- Conditions
- Blood Protein Disorders, Bone Marrow Diseases, Burkitt Lymphoma, +47 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- University of Minnesota Cancer Center Minneapolis, Minnesota, United States
Completed
Busulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT)
NCT00361140
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hematologic Neoplasms, +16 more
- Locations
-
- H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
NCT00891618
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +20 more
- Locations
-
- UT MD Anderson Cancer Center Houston, Texas, United States